Bringing HIV Prevention and Treatment to People Who Use Drugs
Ending HIV: Bringing Integrated Prevention and Treatment Services to People Who Use Drugs Where They Live
This initiative aims to bring HIV prevention and treatment services directly to people who use drugs to help end the HIV epidemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11095817 on NIH RePORTER |
What this research studies
This initiative plans to train community health workers from affected areas to offer HIV testing and diagnose opioid use disorder. It will also create mobile clinics and pharmacies on wheels to deliver immediate access to HIV prevention medication (PrEP), HIV treatment (ART), and medication for opioid use disorder (MOUD) right where people live. These mobile teams, supported by online clinicians, will respond quickly to community needs, making it easier for individuals to get the care they need.
Who could benefit from this research
Good fit: Ideal candidates for this type of intervention would be individuals who use drugs and are at risk for or living with HIV, or those needing treatment for opioid use disorder.
Not a fit: Patients who do not use drugs or are not at risk for HIV or opioid use disorder would likely not directly benefit from these specific services.
Why it matters
Potential benefit: This work could significantly reduce new HIV infections and overdose deaths by making essential prevention and treatment services more accessible to people who use drugs.
How similar studies have performed: While the integrated mobile approach is innovative, individual components like PrEP, ART, and MOUD have established effectiveness in preventing and treating HIV and substance use disorders.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Springer, Sandra Ann — Yale University
- Study coordinator: Springer, Sandra Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.